PRF Technologies Ltd. (PRFX) Stock Score, Valuation & Financial Research

PRF Technologies Ltd. is in the Healthcare sector and Drug Manufacturers - Specialty & Generic industry. It is reviewed using Wall Street Score's company-strength, valuation, growth and financial-health framework. The current Wall Street Score is 19/100.

Quick answer for PRFX

PRF Technologies Ltd. currently has a Wall Street Score of 19/100. The stored market price is $1.02. Its financial score is 12/100. Its valuation score is 0/100. These figures are a research snapshot, not a buy or sell recommendation.

What PRF Technologies Ltd. does

PRF Technologies Ltd. operates as a specialized pharmaceutical company, currently in the clinical development stage, with a focus on pioneering treatments that deliver sustained post-surgical pain management. Central to its pipeline is PRF-110, a distinctive clear, viscous, oil-based solution. This innovative product is engineered for direct application into surgical incisions, aiming to provide targeted and prolonged alleviation of discomfort following operations. PRF-110 is presently undergoing assessment in two pivotal Phase 3 clinical trials, specifically for individuals recovering from bunionectomy and hernia repair procedures. The company, which was originally incorporated in 2007 under the name PainReform Ltd., maintains its headquarters in Tel Aviv, Israel.

PRFX financial snapshot

Wall Street Score:: 19/100
Current price:: $1.02
Market capitalization:: $82K
Revenue:: $40K
Net income:: $-8.9M
Free cash flow:: $-4.0M
Cash:: $8.5M
Total debt:: $50K
EPS:: -11.16
Financial score:: 12/100
Valuation score:: 0/100

What stands out

Reported year-over-year revenue growth is +1.3%.
Free cash flow is $-4.0M, showing cash burn in the current stored period.
The balance sheet shows $8.5M of cash versus $50K of total debt, leaving more cash than debt.
The current research record carries a share basis reconciled warning, which should be reviewed alongside the score.

Questions worth answering for PRFX

These questions are derived from the company's current stored financial and score data so the page adds company-specific research context instead of treating the headline score as a stand-alone conclusion.

Can PRFX maintain its current revenue growth rate and improve the amount of that revenue that turns into earnings and cash?
How long can PRFX fund negative free cash flow using its current cash position before it may need more debt or new shares?
How is PRFX likely to use its cash advantage: reinvestment, acquisitions, debt reduction, dividends or buybacks?
What specifically needs to improve for PRFX to reach sustainable profitability?
What future growth or profitability would be needed to justify PRFX's current valuation?

What the numbers mean

Its current valuation score is 0/100, which Wall Street Score classifies as weak within the model's valuation framework.

The financial score is 12/100. This is a starting point for reviewing liquidity, leverage and cash-flow strength rather than a stand-alone recommendation.

A strong company and an attractive stock price are not always the same thing. Revenue, earnings, free cash flow, debt, management quality, competitive advantage and valuation should be considered together. Wall Street Score organizes these inputs into a consistent research framework so investors can identify what deserves deeper review.

Data freshness: Financial data last refreshed 2026-09-19.

Research-input completeness: 82% of the scoring inputs required for this public page are currently available.

How to research PRFX

Start by understanding how the company makes money. Then compare revenue and earnings trends, cash generation, debt, liquidity and valuation. Review the company's latest filings and earnings reports before acting on any score or model estimate.

Learn how to analyze a stock · Read the Wall Street Score methodology · Browse other stocks

Data may change as company filings and market prices update. Educational research only; not a buy or sell recommendation.